Additional file 1 of Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype

de Mooij, Cornelis M.; Mitea, Cristina; Mottaghy, Felix M.; Smidt, Marjolein L.; van Nijnatten, Thiemo J. A.

doi:10.6084/m9.figshare.17065930.v1

13550_2021_861_MOESM1_ESM.docx (33.48 kB)

Additional file 1 of Value of 18F-FDG PET/CT for predicting axillary pathologic complete response following neoadjuvant systemic therapy in breast cancer patients: emphasis on breast cancer subtype

journal contribution

posted on 2021-11-23, 04:33 authored by Cornelis M. de Mooij, Cristina Mitea, Felix M. Mottaghy, Marjolein L. Smidt, Thiemo J. A. van Nijnatten

Additional file 1: Table S1. Administered NST regimens per breast cancer subtype. Table S2. Differences in PET-parameters determined on primary tumor between axillary response groups. Table S3. ROC analyses of PET-parameters in predicting axillary response following NST in HER2-positive/TN breast cancer patients.